SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is surging on massive volume as traders bet on its role as a key natural gas supplier amidst European energy supply concerns. The community is actively discussing the stock's low float and the potential for a sustained short squeeze as geopolitical tensions fuel broader interest in energy security plays.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors monitor the commercial launch of YARTEMLEA and weigh upcoming catalysts, including European regulatory milestones and potential milestone payments from the Novo Nordisk partnership. While the community is actively debating the company's valuation and the speed of revenue ramp-up, sentiment remains focused on long-term potential despite recent volatility and discussions around short interest.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1996 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere Energy is attracting significant attention as investors speculate on its potential inclusion in the S&P 500, a move fueled by its strong market position and role in the critical U.S. LNG export sector. Meanwhile, the community is actively debating the stock's growth trajectory and its value proposition compared to emerging competitors like Venture Global, with sentiment heavily influenced by geopolitical energy shifts and robust institutional interest.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors react to a significant stock price drop following a quarterly earnings report that showed revenue missing estimates and a continued full-year loss. The community is heavily divided between bears pointing to the company's high debt levels and poor leadership performance, and bulls who are buying the dip in anticipation of future cost reductions and a long-awaited strategic partnership with POSCO.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

The VanEck Gold Miners ETF (GDX) is facing significant downward pressure as investors re-evaluate positions following historic volatility in precious metals and broader market corrections. Community sentiment is deeply divided, with many traders debating whether current price action represents a healthy consolidation phase for a long-term bull market or a deeper structural trend reversal fueled by rising production costs and fluctuating bond yields.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is seeing heightened interest due to its proposed secondary listing in Hong Kong, a move the market is scrutinizing against recent shifts in Chinese regulatory policy. While the potential for a fresh capital raise and increased Asia-Pacific exposure remains a bullish focal point for the community, sentiment remains cautious as traders navigate thin liquidity and ongoing debates over regulatory risks.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is seeing significant investor attention driven by its progress in chemical recycling, specifically the recent transition of its Next Generation Process (NGP) pilot plant to operating campaigns. The community is actively discussing the stock's long-term potential as a solution to global plastic waste, with ongoing debates surrounding the company's pilot-scale milestones and its ability to secure binding partnerships for commercial scale-up.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is currently attracting significant attention as investors weigh its robust demand for AI-driven semiconductor equipment against ongoing concerns regarding U.S.-China export restrictions. The community is actively debating the stock's long-term resilience, with many weighing the company's critical role in the semiconductor supply chain against potential geopolitical headwinds and valuation volatility.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as the community speculates on the potential passage of the Clarity Act, with many hoping it will establish the token as a digital commodity and clarify its long-term utility for collateralized payments. While long-term holders debate whether recent price fluctuations represent institutional accumulation or ongoing market manipulation, community sentiment remains sharply divided between those calling for patience in anticipation of institutional adoption and those frustrated by the prolonged downward trend and perceived lack of clear communication from project leadership.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirm Holdings is currently a major point of contention among investors as they navigate a challenging macro environment, with community debates centering on the firm's transition to GAAP profitability versus persistent concerns over rising credit loss provisions and delinquency rates. Market participants are actively scrutinizing the stock's high-beta volatility, specifically tracking how its BNPL business model holds up against broader sector pressures and recent insider selling activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's Going On With 60 Degrees Pharmaceuticals On Friday?

60 Degrees Pharma shares fall premarket after a huge rally as its babesiosis trial reports a 100% cure rate with tafenoquine treatment.read more...

Promising Small Cap Stocks To Consider - January 22nd

Spring Valley Acquisition, 60 Degrees Pharmaceuticals, and Namib Minerals are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of...

Pharmaceutical Stocks To Consider - January 22nd

Abbott Laboratories, Eli Lilly and Company, 60 Degrees Pharmaceuticals, Novo Nordisk A/S, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool...

60 Degrees Pharmaceuticals Soars After Runway Health Partnership

60 Degrees Pharmaceuticals shares are trading higher after the company announced a partnership with Runway Healthread more...

<ul class="summary-bullets"><li>Arakoda is currently the only broad-spectrum, once-weekly malaria prevention option in the U.S. for international travelers approved by the FDA, the company said.</li><li>60 Degrees stated that the partnership with Runway Health commences on April 2, 2026.</li><li>Eligible travelers will be able to align their travel itinerary with a personalized medical treatment plan designed by a licensed healthcare provider.</li></ul>60 Degrees Pharmaceuticals Inc. (SXTP) shares soared more than 161% in Thursday’s pre-market trade after the company announced a new partnership to expand access to its malaria prevention medicine.60 Degrees has partnered with Runway Health to offer international travelers access to Arakoda through the latter’s travel medicine platform.Arakoda is currently the only broad-spectrum, once-weekly malaria prevention option in the U.S. for international travelers approved by the Food and Drug Administration (FDA), the company said.<h2 class="st-heading-2">What Does The Partnership Offer?</h2>60 Degrees stated that the partnership with Runway Health commences on April 2, 2026. Eligible travelers will be able to match their travel itinerary with a personalized medical treatment plan that is designed by a licensed healthcare provider, the company said.Runway Health is a telehealth platform that offers users access to online consultations led by physicians. This direct-to-patient service allows users to consult with healthcare providers before their departure to regions of the world where certain illnesses, such as malaria, may be prevalent.After the consultation, based on the healthcare providers' advice, users will receive home delivery of the prescribed medication prior to their departure.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/SXTP">60 Degrees</a> was in the ‘extremely bullish’ territory, with message volumes at ‘extremely high’ levels.One bullish user stated they will wait for a buying opportunity in SXTP stock.<stembedurl>https://stocktwits.com/Mrmessiah/message/642530478</stembedurl><a href="https://stocktwits.com/symbol/SXTP">SXTP stock</a> is down 2% year-to-date and 88% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-greenland-piece-of-golden-dome-dow-futures-rise/cmUzUjPR4Qw">Trump Reportedly Says A Piece Of Golden Dome Will Be On Greenland — Dow Futures Rise Over 100 Points</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a trending stock chart.

SXTP Stock Rockets 161% Pre-Market — What Is Driving The Surge?

60 Degrees has partnered with Runway Health to offer international travelers access to Arakoda via Runway Health’s travel medicine platform.

Equity

Here's Why 60 Degrees Pharmaceuticals Inc. (SXTP) Looks Ripe for Bottom Fishing

60 Degrees Pharmaceuticals Inc. (SXTP) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Ardelyx (ARDX) Reports Q2 Loss, Tops Revenue Estimates

Ardelyx (ARDX) delivered earnings and revenue surprises of +38.46% and +15.39%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

Current Price	$1.95
Prev Close	$1.93
Open	$1.95
Dividend Yield	0.00%
50-Day Moving Average	$3.08
Beta	0.00
Avg. Volume	247,654.10
PE Ratio	-0.07

52-Week High	$17.68
52-Week Low	$1.36
Market Capitalization	$4.77M
EPS (Annual)	-$74.18
Price to Book	-0.39
Revenue Per Employee	$227,115.00

SXTP
60 Degrees Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SXTP News

SXTP60 Degrees Pharmaceuticals Inc